Biomedcode is pleased to announce that it has received national funding from the General Secretary for Research and Technology supporting the innovative research networks HUPLA and BreasCaRANKL that combine the efforts of industrial and renowned academic partners to develop precision drug evaluation tools  for the preclinical development of novel therapies for Multiple Sclerosis and Breast Cancer. Read More